Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 8565907, 14 pages
http://dx.doi.org/10.1155/2016/8565907
Review Article

The Effect of Chinese Herbal Medicine Gualouxiebaibanxia Decoction for the Treatment of Angina Pectoris: A Systematic Review

1Department of Cardiology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China
2Department of Cardiology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China

Received 3 April 2016; Accepted 8 August 2016

Academic Editor: Giuseppe Caminiti

Copyright © 2016 Wei Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J.-C. Tardif, “Coronary artery disease in 2010,” European Heart Journal, vol. 12, pp. C2–C10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Braunwald and D. A. Morrow, “Unstable angina: is it time for a requiem?” Circulation, vol. 127, no. 24, pp. 2452–2457, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Zarifis, V. Grammatikou, M. Kallistratos, and A. Katsivas, “Treatment of stable angina pectoris with ivabradine in everyday practice: a pan-hellenic, prospective, noninterventional study,” Clinical Cardiology, vol. 38, no. 12, pp. 725–732, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. GBD 2013 Mortality and Causes of Death Collaborators, “Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013,” The Lancet, vol. 385, no. 9963, pp. 117–171, 2015. View at Publisher · View at Google Scholar
  5. J. S. Kanu, Y. Gu, S. Zhi et al., “Single nucleotide polymorphism rs3774261 in the AdipoQ gene is associated with the risk of coronary heart disease (CHD) in Northeast Han Chinese population: a case-control study,” Lipids in Health and Disease, vol. 15, no. 1, article 6, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. D. M. Lloyd-Jones, Y. Hong, D. Labarthe et al., “Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic impact goal through 2020 and beyond,” Circulation, vol. 121, no. 4, pp. 586–613, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. C. A. Daly, B. De Stavola, and K. M. Fox, “Predicting prognosis in stable angina-results from the Euro heart survey of stable angina: Prospective observational study,” The British Medical Journal, vol. 332, no. 7536, pp. 262–265, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Fox, M. A. Alonso Garcia, D. Ardissino et al., “Guidelines on the management of stable angina pectoris: Executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology,” European Heart Journal, vol. 27, no. 11, pp. 1341–1381, 2006. View at Publisher · View at Google Scholar
  9. J. F. Beltrame, A. J. Weekes, C. Morgan, R. Tavella, and J. A. Spertus, “The prevalence of weekly angina among patients with chronic stable angina in primary care practices,” Archives of Internal Medicine, vol. 169, no. 16, pp. 1491–1499, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. A. Hlatky, D. B. Boothroyd, K. A. Melsop et al., “Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease,” Circulation, vol. 110, no. 14, pp. 1960–1966, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. J. M. Tarkin and J. C. Kaski, “Pharmacological treatment of chronic stable angina pectoris,” Clinical Medicine, vol. 13, no. 1, pp. 63–70, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Wee, K. Burns, and N. Bett, “Medical management of chronic stable angina,” Australian Prescriber, vol. 38, no. 4, pp. 131–136, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Münzel and T. Gori, “Nitrate therapy and nitrate tolerance in patients with coronary artery disease,” Current Opinion in Pharmacology, vol. 13, no. 2, pp. 251–259, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Ren, D. Li, H. Zheng et al., “Acupoint application in patients with chronic stable angina pectoris: study protocol of a randomized, double-blind, controlled trial,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 619706, 8 pages, 2014. View at Publisher · View at Google Scholar
  15. Y.-F. Ding, Y.-R. Peng, J. Li, H. Shen, M.-Q. Shen, and T.-H. Fang, “Gualou Xiebai Decoction prevents myocardial fibrosis by blocking TGF-beta/Smad signalling,” Journal of Pharmacy and Pharmacology, vol. 65, no. 9, pp. 1373–1381, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. H.-M. Zhang, D.-L. Tang, L. Tong et al., “Gualou Xiebai Banxia Decoction inhibits NF-kappa B-dependent inflammation in myocardial ischemia-reperfusion injury in rats,” Journal of Traditional Chinese Medicine, vol. 31, no. 4, pp. 338–343, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. X. J. He, N. L. Wang, F. Qiu, and X. S. Yao, “Study on the active spirostanol saponins of Gualou xiebai baijiutang,” Yao Xue Xue Bao, vol. 38, no. 6, pp. 433–437, 2003. View at Google Scholar
  18. H.-Y. Yan, C.-C. Zou, M.-L. Wei, Z.-Z. Gao, and Y. Yang, “Pharmacodynamics Study on gualou xiebai dropping pills and its medicinal ingredients in prescription,” Zhong Yao Cai, vol. 38, no. 3, pp. 567–571, 2015. View at Google Scholar · View at Scopus
  19. G. X. Chen, “Clinical observation of Gualou xiebai banxia Decoction on angina pectoris,” Hubei Journal of Traditional Chinese Medicine, vol. 10, no. 3, pp. 40–42, 2008. View at Google Scholar
  20. J. M. Bai and W. F. Shi, “Clinical observation and analysis of Gualou xiebai banxia Decoction for 48 cases of angina,” Journal of Sichuan of Traditional Chinese Medicine, vol. 25, no. 9, pp. 64–65, 2007. View at Google Scholar
  21. J. D. Yang and D. H. Zhou, “Clinical observation of Gualou xiebai banxia Decoction for 32 cases of angina,” JETCM, vol. 16, no. 12, pp. 1530–1532, 2007. View at Google Scholar
  22. X. F. Hu, “Clinical observation on 36 cases of angina pectoris of coronary heart disease treated by gualou xiebai banxia decoction,” Hunan Guiding Journal of TCMP, vol. 7, no. 9, pp. 454–456, 2001. View at Google Scholar
  23. D. F. Zhang and X. L. Li, “Clinical observation of Gualou xiebai banxia Decoction for 56 cases with angina pectoris of coronary heart disease,” Clinical Journal of Traditional Chinese Medicine, vol. 25, no. 9, pp. 770–772, 2013. View at Google Scholar
  24. Y. H. He, Y. Cai, and S. D. Luo, “Clinical observation on treating 58 cases of angina pectoris of coronary heart disease with gualouxiebaibanxia decoction addition,” Guiding Journal of TCM, vol. 12, no. 2, pp. 62–64, 2006. View at Google Scholar
  25. P. F. Shi, K. Wang, Q. L. Li et al., “Observation of gualou xiebai banxia decoction combined with western medicine treating 45 cases of coronary heart disease angina pectoris,” Modern Traditional Chinese Medicine, vol. 33, no. 6, pp. 11–13, 2013. View at Google Scholar
  26. J. X. Si and Z. J. Yin, “Clinical observation of flavored gualou xiebai and banxia decoction in the treatment of unstable angina of coronary heart disease,” China Journal of Chinese Medicine, vol. 27, no. 172, pp. 1101–1103, 2012. View at Google Scholar
  27. Z. Z. Wang, “Clinical observation on 68 cases of angina pectoris of coronary heart disease treated by gualou xiebai banxia decoction,” CJGMCM, vol. 27, no. 5, pp. 927–929, 2012. View at Google Scholar
  28. Z. Q. Zhang and W. Z. Zhu, “Clinical observation of Gualou xiebai banxia decoction for 60 cases with angina pectoris of coronary heart disease,” Zhejiang JITCWM, vol. 13, no. 13, pp. 248–249, 2003. View at Google Scholar
  29. H. B. Fang, “Observation of gualou xiebai banxia decoction combined with western medicine treating 34 cases of coronary heart disease angina pectoris,” Zhejiang Journal of Traditional Chinese Medicine, vol. 46, no. 6, pp. 418–420, 2011. View at Google Scholar
  30. B. G. Zhu, “Clinical observation and analysis of Gualou xiebai banxia Decoction for 80 cases with angina pectoris of coronary heart disease,” CJGMCM, vol. 27, no. 6, pp. 1256–1257, 2012. View at Google Scholar
  31. J. L. Li and X. B. Cai, “Clinical observation of Flavored Gualou xiebai banxia Decoction for angina pectoris of coronary heart disease,” Public Medical Forum Magazine, vol. 15, pp. 846–848, 2011. View at Google Scholar
  32. H. W. Zhang, “Therapeutic effects of Flavored Gualou xiebai banxia Decoction for 42 patients of angina pectoris of phlegm and blood stasis syndrome,” CJGMCM, vol. 30, no. 11, pp. 2439–2441, 2015. View at Google Scholar
  33. P. Ma, “Randomized parallel group study Gualou Xiebai soup combined with Western treatment of Angina Pectoris,” Journal of Practical Traditional Chinese Internal Medicine, vol. 29, no. 9, pp. 110–112, 2015. View at Google Scholar
  34. Q. F. Yang, D. F. Bi, H. B. Wu et al., “Clinical observation of Gualouxiebaibanxia Decoction combined with Nitroglycerin Injection for 42 cases with angina pectoris of coronary heart disease,” Guide of Chinese Medicine, vol. 13, no. 1, pp. 228–229, 2015. View at Google Scholar
  35. R. X. Tong and S. Q. Xiong, “Phlegm method for unstable angina plasma ox-LDL levels affect random parallel control study,” Journal of Practical Traditional Chinese Internal Medicine, vol. 27, no. 9, pp. 62–64, 2013. View at Google Scholar
  36. W. Q. Wang, “Clinical observation of Gualou xiebai banxia Decoction for angina pectoris of coronary heart disease,” Heibei Medicine, vol. 21, no. 6, pp. 1033–1035, 2015. View at Google Scholar
  37. F. Q. Yang, “Clinical observation of modified Gualou xiebai banxia Decoction for 80 cases with angina pectoris of coronary heart disease,” China Medical Engineering, vol. 23, no. 8, pp. 125–127, 2015. View at Google Scholar
  38. E. Rapaport, R. Bernard, and E. Corday, “Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on standardization of clinical nomenclature,” Circulation, vol. 59, no. 3, pp. 607–609, 1979. View at Publisher · View at Google Scholar · View at Scopus
  39. R. J. Gibbons, J. Abrams, P. C. Deedwania et al., “ACC/AHA practice guidelines-ACC/AHA 2002 guideline update for the management of patients with chronic stable angina task force on practice guidelines (committee to update the 1999 guidelines),” Circulation, vol. 107, no. 1, pp. 149–158, 2002. View at Google Scholar
  40. J. P. T. Higgins and S. Green, “Corchrane Reviewers' Handbook 5.1.0 [updated March 2011], Review Manager (RevMan) [Computer program]. Version 5.1.0”.
  41. V. A. Barnes and D. W. Orme-Johnson, “Prevention and treatment of cardiovascular disease in adolescents and adults through the transcendental meditation program: a research review update,” Current Hypertension Reviews, vol. 8, no. 3, pp. 227–242, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. E.-M. Backé, A. Seidler, U. Latza, K. Rossnagel, and B. Schumann, “The role of psychosocial stress at work for the development of cardiovascular diseases: a systematic review,” International Archives of Occupational and Environmental Health, vol. 85, no. 1, pp. 67–79, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. G. Kourlaba, C. Vlachopoulos, J. Parissis, J. Kanakakis, G. Gourzoulidis, and N. Maniadakis, “Ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Greece: a cost-utility study,” BMC Health Services Research, vol. 15, no. 1, article 566, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Vigen, J. A. Spertus, T. M. Maddox et al., “Hospital-level variation in angina and mortality at 1 year after myocardial infarction: insights from the Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH) registry,” Circulation: Cardiovascular Quality and Outcomes, vol. 7, no. 6, pp. 851–856, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Y. Park, J. K. Paik, O. Y. Kim, J. S. Chae, Y. Jang, and J. H. Lee, “Interactions between the APOA5-1131T > C andthe FEN1 10154G > T polymorphisms onω6 polyunsaturatedfatty acids in serum phospholipids and coronary artery disease,” The Journal of Lipid Research, vol. 51, no. 11, pp. 3281–3288, 2010. View at Publisher · View at Google Scholar
  46. D. Kong, Y. Wang, Y. Liu et al., “The association between blood lipid and phlegm turbidity syndrome of angina pectoris: a systematic review and meta-analysis,” Complementary Therapies in Medicine, vol. 22, no. 4, pp. 801–813, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. P. Mata, R. Alonso, A. Lopez-Farre et al., “Effect of dietary fat saturation on LDL oxidation and monocyte adhesion to human endothelial cells in vitro,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 16, no. 11, pp. 1347–1355, 1996. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Toborek, Y. W. Lee, R. Garrido, S. Kaiser, and B. Hennig, “Unsaturated fatty acids selectively induce an inflammatory environment in human endothelial cell,” The American Journal of Clinical Nutrition, vol. 75, no. 1, pp. 119–125, 2002. View at Google Scholar · View at Scopus
  49. M. Toborek, S. W. Barger, M. P. Mattson, S. Barve, C. J. McClain, and B. Hennig, “Linoleic acid and TNF-α cross-amplify oxidative injury and dysfunction of endothelial cells,” Journal of Lipid Research, vol. 37, no. 1, pp. 123–135, 1996. View at Google Scholar · View at Scopus
  50. C. Y. Ha, J. Y. Kim, J. K. Paik et al., “The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes,” Clinical Endocrinology, vol. 76, no. 5, pp. 674–682, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Y. Park, S.-H. Lee, M.-J. Shin, and G.-S. Hwang, “Alteration in metabolic signature and lipid metabolism in patients with angina pectoris and myocardial infarction,” PLoS ONE, vol. 10, no. 8, Article ID e0135228, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. K. R. Bagale, A. S. Ingle, and R. Choudhary, “Contribution of various lipid profile parameters in determining creatine kinase-MB levels in unstable angina patients,” International Journal of Applied and Basic Medical Research, vol. 6, no. 2, pp. 106–110, 2016. View at Publisher · View at Google Scholar
  53. X. Xiong, P. Wang, X. Li, and Y. Zhang, “Qigong for hypertension: a systematic review,” Medicine, vol. 94, no. 1, pp. 1–14, 2015. View at Publisher · View at Google Scholar · View at Scopus